2500 patienter i forsøg som undersøgte effekten på metabolisme og vægttab hos overvægtige og stærkt overvægtige patienter og hos ca.
or uth ZIMULTI 20 mg has been evaluated for safety in approximately 2500 patients enrolled in studies that examined the metabolic and weight loss effects in overweight and obese patients and in approximately 3800 patients in other indications.